Regulation Text
Authority
21 U.S.C. 321,343,346,346a,348,350a,350b,352,353,355,360,360c-360f,360h-360j,371,379e,381;42 U.S.C. 216,241,262.
Related Warning Letters (1)
- 2025-03-25
Clinical Investigator
Americo F. Padilla, M.D.
Related Guidelines (5)
Use of Electronic Informed Consent in Clinical Investigations – Questions and Answers: Guidance for Institutional Review Boards, Investigators, and Sponsors (Status: Final)
→Saline, Silicone Gel, and Alternative Breast Implants: Guidance for Industry and FDA Staff (Status: Final)
→Informed Consent: Guidance for IRBs, Clinical Investigators, and Sponsors (Status: Final)
→Considerations for the Conduct of Clinical Trials of Medical Products During Major Disruptions Due to Disasters and Public Health Emergencies (Status: Final)
→Key Information and Facilitating Understanding in Informed Consent Guidance for Sponsors, Investigators, and Institutional Review Boards (Status: Draft)
→